the aid library

LIST OPTIONS

Filter

1430

Sort by:

Direction:

Download (1714)

View PDF (5754)

Infection Control for Viral Haemorraghic Fever in the African Health Care Setting

Centers for Disease Control and Prevention , World Health Organization WHO (1998)

Important Guideline for Ebola prevention and control It is designed for the following uses: - for prevention through preparedness--to help African health facilities make advance preparations for responding with appropriate precautions when a VHF (including Ebola) case is suspected. - for pl... more

Download (1132)

View PDF (1365)

Implementation and management of contact tracing for Ebola virus disease

World Health Organization (WHO); CDC (2015) C_WHO

The document covers: introduction on contact tracing in the Ebola response; general considerations for contact tracing; case definition; planning and preparation; personnel; implementation, and tools for contact tracing.

Download (445)

View PDF (278)

Standard Operating Procedures on Viral Load Monitoring for ICAP Clinical Staff and Health Care Workers: A Template Document for Country Adaptation

ICAP (2016) C1

Version 1.1 July 2016
The purpose of this document is to describe standard operating procedures for viral load monitoring, including the schedule for viral load testing when used for routine monitoring of children, adolescents and adults on ART; interpretation of results; patient management; an... more

Download (201)

View PDF (325)

Guidelines for Handling Decedents Contaminated with Radioactive Materials

Wood MC, DePaolo, F, Whitaker RD Centers for Disease Control and Prevention (CDC) (2007) C_CDC

Detonation of a nuclear weapon or activation of a radiological dispersal device could cause radioactively contaminated decedents. These guidelines are designed to address both of these scenarios. They could also be applicable in other instances where decedents’ bodies are contaminated with radioa... more

Download (716)

View PDF (1236)

Guidelines for the production, control and regulation of snake antivenom immunoglobulins

World Health Organization (WHO) (2017) C_WHO

Replacement of Annex 2 of WHO Technical Report Series, No. 964... more

Download (812)

View PDF (1623)

Liberia: handling of bodies and national memorials – community perceptions from Monrovia

Juliet Bedford UNMEER (2014)

Download (82)

View PDF (145)

Trainer’s Guide - Section 2: Preparation

World Health Organization (WHO) World Health Organization (WHO) (2020) C_WHO

Accessed: 08.03.2020 Thorough preparation is essential to the success of your workshop. This section describes the activities that you must carry out in advance of the workshop to assure that the workshop achieves expected outcomes. Information on the basics of training (Section 3) should also be... more

Download (91)

View PDF (122)

Considerations related to the safe handling of bodies of deceased persons with suspected or confirmed COVID-19

European Centre for Disease Prevention and Control ECDC (2020) C1

This document aims to support public health preparedness planning and response activities on the safe handling of bodies of deceased persons with suspected or confirmed COVID-19: at the site of death, during transport, storage and preparation before burial/cremation, and during burial/cremation.

Download (137)

View PDF (109)

COVID-19 Basic Measures: For healthcare and deathcare workers in the handling of the dead

International Federation of Red Cross And Red Crescent Societies IFRC (2020) C1

The wearing of Personal Protective Equipment (PPE) is standard practice for the handling of the deceased and should be carried out in line with standard Health and Safety procedures. Healthcare and deathcare workers should take precautions when handling the remains of individuals who have died fr... more

Download (195)

View PDF (164)

Planning and Implementing High-Quality Supplementary Immunization Activities for Injectable Vaccines Using an Example of Measles and Rubella Vaccines

World Health Organization WHO (2016) C_WHO

The purpose of this field guide is to provide comprehensive information on planning and implementing high-quality3 SIAs for injectable vaccines and highlight the opportunities to strengthen RI and surveillance. The guide uses measles–rubella SIAs as the main example throughout, but the informatio... more

Download (515)

View PDF (119)

Guide for the preparation of a risk communication strategy for COVID-19 vaccines: A Resource for the countries of the Americas

Pan American Health Organisation PAHO (2021) C_WHO

This document facilitate the preparation of a risk communication and community engagement strategy for vaccination against COVID-19. Its goal is to help to strengthen the communication and planning capacities of the ministries or secretariats of health and other agencies in charge of communicating ... more

Download (111)

View PDF (153)

Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
recommended

World Health Organization WHO (2021) C_WHO

4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT) conditions. Prior to use the vaccine can be transferred to -20ºC freezer or +2-8ºC refrigerator at... more

Download (267)

View PDF (204)

ASHP Guidelines on Pharmacy-Prepared Ophthalmic Products

American Society of Hospital Pharmacists (ASHP) ASHP (2008) CC

Drug Distribution and Control: Preparation and Handling–Guidelines Review 2008

Download (129)

View PDF (188)

ASHP Technical Assistance Bulletin on Compounding Nonsterile Products in Pharmacies

American Society of Hospital Pharmacists (ASHP) ASHP (1994) CC

Drug Distribution and Control: Preparation and Handling This Technical Assistance Bulletin is intended to assist pharmacists in the extemporaneous compounding of non-sterile drug products for individual patients. Included in this document is information on facilities and equipment, ingredient... more

Download (200)

View PDF (252)

Guidance for registered pharmacies preparing unlicensed medicines: revison 2018

General Pharmaceutical Council Genral Pharmaceutical Council UK (2018) CC

This guidance should be followed if an unlicensed medicine is prepared in a registered pharmacy. The preparation of an unlicensed medicine (for example unlicensed methadone, or menthol in aqueous cream) in a pharmacy is called ‘extemporaneous preparation’. The guidance should be read alon... more

Download (148)

View PDF (187)

Control measures for Shiga toxin-producing Escherichia coli (‎STEC)‎ associated with meat and dairy products: meeting report

World Health Organisation (WHO) (2022) C_WHO

Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the... more

Download (102)

View PDF (516)

Certified African Regional professionals: Level 1 Biological Waste Management

Africa Center for Disease Control and Prevention (2023) CC

The Africa Centres for Disease Control and Prevention (Africa CDC) Biosafety and Biosecurity Initiative was launched by the Africa CDC in April 2019 with the aim of strengthening the African Union (AU) Member States’ biosafety and biosecurity systems and enabling them to comply with national and i... more

Download (106)

View PDF (485)

Certified African Regional professionals: Level 1 Biorisk Management

Africa Center for Disease Control and Prevention (2023) CC

Download (80)

View PDF (116)

Pediatric oncology nursing practice in Latin America and the Caribbean

Pan American Health Organisation PAHO (2024) C_WHO

One of the main aims of the WHO Global Initiative for Childhood Cancer and the CureAll Americas framework is to strengthen centers of excellence and promote the training of the health workforce, especially pediatric oncology nurses, specialized in nursing care for children and adolescents with cance... more

Download (3)

View PDF (2)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) recommended

Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
recommended